198 related articles for article (PubMed ID: 14299158)
1. [THERAPEUTIC PROBLEMS ON THE SUBJECT OF OBLITERATING ARTERIAL DISEASES OF THE LEGS: PERSONAL EXPERIENCES WITH A NICOTINIC ACID DERIVATIVE, TETRANICOTINOYL FRUCTOSE (BRADILAN)].
ORICOLI L
Osp Ital Chir; 1965 Jan; 12():71-82. PubMed ID: 14299158
[No Abstract] [Full Text] [Related]
2. A method of treatment of obliterating endarteriitis, with trophic lesions, in the extremities; the eutrophic effect of niacin derivatives.
PRUSIK B
Cardiologia (Basel); 1949; 14(1-2):81-93. PubMed ID: 18149979
[No Abstract] [Full Text] [Related]
3. [MEDICO-SURGICAL TREATMENT OF OBLITERATING ARTERIOPATHIES OF THE LOWER EXTREMITIES WITHOUT ACUTE ISCHEMIA. THE POINT OF VIEW OF THE PHYSICIAN].
NORMAND J
J Med Lyon; 1964 Jan; 45():55-63. PubMed ID: 14125141
[No Abstract] [Full Text] [Related]
4. [RESULTS ON THE USE IN OPHTHALMOLOGY OF A NEW VASODILATOR: TETRANICOTINOYL-FRUCTOSE].
MANFREDINI U
Minerva Oftalmol; 1964; 6():93-6. PubMed ID: 14187591
[No Abstract] [Full Text] [Related]
5. [TREATMENT OF THE CUTANEOUS ISCHEMIA OF OCCLUSIVE ARTERIOSCLEROSIS OF THE EXTREMITIES WITH A VASODILATING PREPARATION OF LOCAL ACTION].
BUZZI A; CIBEIRA JB
Sem Med; 1963 Dec; 123():1973-7. PubMed ID: 14128161
[No Abstract] [Full Text] [Related]
6. [EXPERIENCES WITH THE MEDICAL TREATMENT OF ARTERIOSCLEROSIS OBLITERANS].
LUCZAK S; BUECHNER H
Med Klin; 1964 May; 59():738-40. PubMed ID: 14225422
[No Abstract] [Full Text] [Related]
7. Beneficial effects of vitamin A niacin and riboflavin in the management of certain types of vascular conditions.
FISKE S; FOX LP; CAVUSOGLU M
Med Times; 1962 Oct; 90():1055-64. PubMed ID: 13945325
[No Abstract] [Full Text] [Related]
8. [A FEW IDEAS CONCERNING THE ETIOLOGY OF CHRONIC ARTERIOPATHIES OF THE EXTREMITIES].
PERRIN A
J Med Lyon; 1964 Jan; 45():16-20. PubMed ID: 14125136
[No Abstract] [Full Text] [Related]
9. [THE RESULTS OF ELECTROMYOGRAPHIC STUDIES OF OBLITERATING ARTERIAL DISEASES].
KOWALSKA M
Pol Arch Med Wewn; 1964; 34():1201-12. PubMed ID: 14235108
[No Abstract] [Full Text] [Related]
10. [Our experience with tetranicotinoyl-fructose in the treatment of peripheral vascular diseases].
GUERRA G
Riforma Med; 1962 Sep; 76():966-70. PubMed ID: 13951107
[No Abstract] [Full Text] [Related]
11. [7-(3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL)-1, 3-DIMETHYL-XANTHINE NICOTINATE IN CHRONIC OBLITERATING ANGIOPATHIES].
FERNANDEZBLANCO E; DEFERNANDEZBLANCO JF; AGUSTINARZENO J
Sem Med; 1963 Nov; 123():1733-40. PubMed ID: 14110181
[No Abstract] [Full Text] [Related]
12. [INDIRECT FIBRINOLYTIC AND ANTICOAGULANT TREATMENT OF THROMBOSIS].
MENEGHINI P; AVANZI G
Policlinico Prat; 1964 May; 71():803-20. PubMed ID: 14159143
[No Abstract] [Full Text] [Related]
13. [FEATURES OF CHANGES IN SOME HEMODYNAMIC INDICES IN THE CLINICAL PICTURE OF THROMBO-OBLITERATING DISEASES OF THE LEGS].
KARPIK AI
Zdravookhr Beloruss; 1963 Nov; 9():17-9. PubMed ID: 14150562
[No Abstract] [Full Text] [Related]
14. [Experiences with the treatment of peripheral vascular diseases with Xavin].
Brücknerová O
Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
[No Abstract] [Full Text] [Related]
15. VASCULAR DISEASES OF THE LIMBS.
CARTIER GE
Can Nurse; 1964 Mar; 60():224-32. PubMed ID: 14126081
[No Abstract] [Full Text] [Related]
16. [CIRCULATORY RESEARCH ON ELEDOISIN WITH RESULTS OF THERAPY].
GERSMEYER EF; CASTENHOLZ A; NICOLAY M
Klin Wochenschr; 1965 Mar; 43():309-17. PubMed ID: 14284893
[No Abstract] [Full Text] [Related]
17. [BASAL METABOLISM IN PATIENTS WITH THROMBO-OBLITERATING DISEASES OF THE LEG ARTERIES AND ITS ALTERATION DURING THERAPY].
KUNTSEVICH VI
Zdravookhr Beloruss; 1964 Jan; 10():63-5. PubMed ID: 14178602
[No Abstract] [Full Text] [Related]
18. [PATHOPHYSIOLOGY OF OBLITERATIVE ARTERIOPATHIES].
KAINDL F
Klin Med Osterr Z Wiss Prakt Med; 1963 Oct; 18():469-79. PubMed ID: 14160523
[No Abstract] [Full Text] [Related]
19. [REMOTE RESULTS OF TREATMENT OF PATIENTS WITH OBLITERATING ARTERIAL DISEASE].
MAZURIK MF
Khirurgiia (Mosk); 1963 Nov; 39():98-102. PubMed ID: 14141041
[No Abstract] [Full Text] [Related]
20. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
[No Abstract] [Full Text] [Related]
[Next] [New Search]
